Phocas Financial Corp. - DIPLOMAT PHARMACY INC ownership

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q3 2018$3,895,000
-25.4%
200,649
-1.8%
0.34%
-24.1%
Q2 2018$5,222,000
-58.7%
204,290
-67.5%
0.45%
-60.6%
Q1 2018$12,654,000
-4.9%
627,999
-5.3%
1.14%
+2.2%
Q4 2017$13,310,000
+221733.3%
663,187
+142.9%
1.12%
+122.3%
Q3 2017$6,000273,0190.50%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders